GSDMD and bacterial infectious disease: The GSDMD−/− mice presented decreased IL-1β and increased Cxcl1 secretion following S. aureus infection, suggesting that upon S. aureus challenge, promotion of IL-1β production or inhibition of Cxcl1 may be the key for the protective effect of GSDMD during bacterial infection.